Aiuti A - Search Results

1

Good Laboratory Practice Preclinical Safety Studies for GSK2696273 (MLV Vector-Based Ex Vivo Gene Therapy for Adenosine Deaminase Deficiency Severe Combined Immunodeficiency) in NSG Mice.

Carriglio N, Klapwijk J, Hernandez RJ, Vezzoli M, Chanut F, Lowe R, Draghici E, Nord M, Albertini P, Cristofori P, Richards J, Staton H, Appleby J, Aiuti A, Sauer AV. Carriglio N, et al. Among authors: aiuti a. Hum Gene Ther Clin Dev. 2017 Mar;28(1):17-27. doi: 10.1089/humc.2016.191. Hum Gene Ther Clin Dev. 2017. PMID: 28319446

2

Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer.

Ruggieri L, Aiuti A, Salomoni M, Zappone E, Ferrari G, Bordignon C. Ruggieri L, et al. Among authors: aiuti a. Hum Gene Ther. 1997 Sep 1;8(13):1611-23. doi: 10.1089/hum.1997.8.13-1611. Hum Gene Ther. 1997. PMID: 9322094

3

Optimisation of retroviral supernatant production conditions for the genetic modification of human CD34+ cells.

Dando JS, Aiuti A, Deola S, Ficara F, Bordignon C. Dando JS, et al. Among authors: aiuti a. J Gene Med. 2001 May-Jun;3(3):219-27. doi: 10.1002/1521-2254(200105/06)3:3<219::AID-JGM184>3.0.CO;2-E. J Gene Med. 2001. PMID: 11437327

4

A novel human packaging cell line with hematopoietic supportive capacity increases gene transfer into early hematopoietic progenitors.

Dando JS, Roncarolo MG, Bordignon C, Aiuti A. Dando JS, et al. Among authors: aiuti a. Hum Gene Ther. 2001 Nov 1;12(16):1979-88. doi: 10.1089/104303401753204553. Hum Gene Ther. 2001. PMID: 11686939

5

Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.

Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, Morecki S, Andolfi G, Tabucchi A, Carlucci F, Marinello E, Cattaneo F, Vai S, Servida P, Miniero R, Roncarolo MG, Bordignon C. Aiuti A, et al. Science. 2002 Jun 28;296(5577):2410-3. doi: 10.1126/science.1070104. Science. 2002. PMID: 12089448 Clinical Trial.

6

Advances in gene therapy for ADA-deficient SCID.

Aiuti A. Aiuti A. Curr Opin Mol Ther. 2002 Oct;4(5):515-22. Curr Opin Mol Ther. 2002. PMID: 12435054 Review.

7

Gene therapy for adenosine deaminase deficiency.

Aiuti A, Ficara F, Cattaneo F, Bordignon C, Roncarolo MG. Aiuti A, et al. Curr Opin Allergy Clin Immunol. 2003 Dec;3(6):461-6. doi: 10.1097/00130832-200312000-00007. Curr Opin Allergy Clin Immunol. 2003. PMID: 14612670 Review.

8

Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-Hu mice.

Deola S, Scaramuzza S, Birolo RS, Carballido-Perrig N, Ficara F, Mocchetti C, Dando J, Carballido JM, Bordignon C, Roncarolo MG, Bregni M, Aiuti A. Deola S, et al. Among authors: aiuti a. Hum Gene Ther. 2004 Mar;15(3):305-11. doi: 10.1089/104303404322886156. Hum Gene Ther. 2004. PMID: 15018739

9

Gene therapy for adenosine-deaminase-deficient severe combined immunodeficiency.

Aiuti A. Aiuti A. Best Pract Res Clin Haematol. 2004 Sep;17(3):505-16. doi: 10.1016/j.beha.2004.05.012. Best Pract Res Clin Haematol. 2004. PMID: 15498720 Review.

10

IL-3 or IL-7 increases ex vivo gene transfer efficiency in ADA-SCID BM CD34+ cells while maintaining in vivo lymphoid potential.

Ficara F, Superchi DB, Hernández RJ, Mocchetti C, Carballido-Perrig N, Andolfi G, Deola S, Colombo A, Bordignon C, Carballido JM, Roncarolo MG, Aiuti A. Ficara F, et al. Among authors: aiuti a. Mol Ther. 2004 Dec;10(6):1096-108. doi: 10.1016/j.ymthe.2004.08.014. Mol Ther. 2004. PMID: 15564141 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters